Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefits of continuous intravenous lidocaine infusion in bariatric surgery
2017-001474-41Phase 3Completed
- Sponsor
- CHU Caen Normandie
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing Lidocaine arm with Placebo arm (2 arms). Primary endpoint: Total postoperative intravenous oxycodone consumption. Started Oct 2017; status: completed.
02
Drugs
lidocaine
03
Conditions
obesity
Beyond the preview
Go deeper on 2017-001474-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001474-41.